# Hsa_circ_0018909 promotes non-small cell lung cancer by directly regulating hsa-miR-513b-5p

## TL;DR

This study shows that a circular RNA called hsa_circ_0018909 promotes non-small cell lung cancer by interacting with a microRNA and increasing tumor growth.

## Contribution

The study identifies a novel regulatory axis involving hsa_circ_0018909, hsa-miR-513b-5p, and MDH1 in non-small cell lung cancer progression.

## Key findings

- Hsa_circ_0018909 is upregulated in NSCLC and is associated with poor survival outcomes.
- Hsa_circ_0018909 promotes cancer cell proliferation, migration, and invasion by sponging hsa-miR-513b-5p.
- MDH1 is a downstream target of hsa-miR-513b-5p and mediates tumor-promoting effects in NSCLC.

## Abstract

Circular RNAs (circRNAs) regulate gene expression by functioning as competing endogenous RNAs (ceRNAs) and are increasingly recognized for their involvement in cancer progression. Hsa_circ_0018909 is upregulated in non-small cell lung cancer (NSCLC); however, its functional role and underlying mechanisms remain poorly understood. This study aimed to investigate the role of hsa_circ_0018909 and its downstream regulatory axis in NSCLC.

Differentially expressed circRNAs were identified from the GSE101586 dataset. The expression levels of hsa_circ_0018909 and hsa-miR-513b-5p were validated in NSCLC tissues and cell lines. CircBase and UCSC were used to determine the genomic origin of hsa_circ_0018909, and its subcellular localization was examined using fluorescence in situ hybridization. The interaction between hsa_circ_0018909 and hsa-miR-513b-5p was predicted with TargetScan and verified through dual-luciferase reporter assays. Functional assays, including CCK-8, colony formation, Transwell migration/invasion, and subcutaneous tumor formation in nude mice, were conducted to evaluate the effects of hsa_circ_0018909. Rescue experiments and Western blot analyses were performed to identify downstream targets and elucidate the underlying regulatory mechanisms.

Among the five upregulated circRNAs identified, only hsa_circ_0018909 consistently showed high expression in NSCLC tissues and cell lines and was associated with shorter overall and disease-free survival. Hsa_circ_0018909 was primarily localized in the cytoplasm. Overexpression of hsa_circ_0018909 enhanced the proliferation, migration, and invasion of NSCLC cells, while its knockdown produced the opposite effects. Hsa-miR-513b-5p mimics attenuated the oncogenic effects of hsa_circ_0018909, whereas inhibition of hsa-miR-513b-5p reversed the suppressive effects of hsa_circ_0018909 knockdown. Mechanistically, hsa_circ_0018909 directly binds to hsa-miR-513b-5p and negatively regulates its expression. Malate dehydrogenase 1 (MDH1) was identified as a direct downstream target of hsa-miR-513b-5p. Rescue experiments confirmed that MDH1 mediates the tumor-promoting effects resulting from hsa-miR-513b-5p inhibition in NSCLC cells.

Hsa_circ_0018909 is significantly upregulated in NSCLC and promotes tumor progression by sponging hsa-miR-513b-5p, thereby indirectly upregulating its downstream target, MDH1. These findings suggest that the hsa_circ_0018909/miR-513b-5p/MDH1 axis may represent a potential therapeutic target for NSCLC.